Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000059478-25-000204
Filing Date
2025-08-07
Accepted
2025-08-07 09:59:55
Documents
74
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lly-20250630.htm   iXBRL 10-Q 1797977
2 EX-31.1 lly-06302025x10qxexhibit311.htm EX-31.1 10570
3 EX-31.2 lly-06302025x10qxexhibit312.htm EX-31.2 10601
4 EX-32 lly-06302025x10qxexhibit32.htm EX-32 7033
  Complete submission text file 0000059478-25-000204.txt   10155819

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20250630.xsd EX-101.SCH 46747
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20250630_cal.xml EX-101.CAL 72677
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20250630_def.xml EX-101.DEF 259010
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20250630_lab.xml EX-101.LAB 640232
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20250630_pre.xml EX-101.PRE 448506
77 EXTRACTED XBRL INSTANCE DOCUMENT lly-20250630_htm.xml XML 2258161
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 251192175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)